Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

STLNSTLN

Showing 2 of 10 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in Starling Oncology, Inc.

No. Qube Research & Technologies exited its STLN (Starling Oncology) position in Q4 2024. Its Q3 2024 13F listed 15,642 shares worth $5,113. Qube Research & Technologies first reported STLN in Q4 2021 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$5,113

Total Shares Change

-15,642

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.31
0
2024-Q3
Unchanged
15,642
0.0%
$5,1130.0%$0.33
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used